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Background Patients (pts) undergoing pace-maker and/or cardioverter-defibrillator (PM/ICD) implantation/upgrade might have difficult access 
due to sub/total central vein occlusions (CVO), usually related to prior venous manipulation. We aimed to describe the feasibility and safety of the 
endovascular approach to recanalize CVO to allow PM/ICD implantation.
Methods From Jan 2007 to Dec 2008, a series of 29 pts who underwent CVO recanalization prior to PM/ICD implantation were included in this 
analysis. Femoral vein was the primary access, and brachial/cephalic vein were used when recanalization was not possible via femoral access. 
Venoplasty was primary attempted by wiring the occlusion site.
Results The mean age was 71.9 years, with a high rate of comorbidities including heart failure (65.5%), chronic renal failure (44.8%), chronic 
hemodialysis (31.0%), and diabetes (27.6%). Angiographic/procedural characteristics are described in the Table. All pts had history of prior venous 
access. Successful CVO recanalization followed by successful PM/ICD implantation/upgrade was achieved in 27 pts (93.1%) without peri-procedural 
complications. Recanalization failed in 2 pts. One patient died during hospitalization due to severe respiratory failure not related to the procedure.
Conclusions We described the feasibility and safety of the endovascular approach to recanalize CVO in pts with poor vascular access to allow 
further PM/ICD implantation/upgrade. 
Table. Angiographic and procedural characteristics
Prior venous access, n (%) n=29
Hemodialysis 11 (37.9%)
Pace-maker (PM) 10 (27.6%)
Implantable cardioverter-defibrillator (ICD) 6 (27.6%)
PM/ICD failed implantation 5 (17.2%)
Current device implantation, n (%) n=27
New device 15 (55.6%)
PM 6 (22.2%)
ICD 4 (14.8%)
Cardiac resynchronization therapy (CRT) 2 (7.4%)
Lead replacement 3 (11.1%)
Upgrade 12 (44.4%)
CRT 9 (33.3%)
ICD 3 (11.1%)
Lesion location, n (%) n=29
Total occluded subclavian vein 15 (51.7%)
Sub-occluded subclavian vein 3 (10.3%)
Total occluded innominate vein 9 (31.0%)
Sub-occluded innominate vein 2 (6.9%)
Procedural access, n (%) n=29
Femoral vein 23 (79.3%)
Brachial vein 3 (10.3%)
Femoral and brachial 3 (10.3%)
Recanalization method, n (%) n=29
Wire 27 (93.1%)
Chronic total occlusion device 2 (6.9%)
